RZRui Zhang

Rui Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Rui Zhang has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Jun-Li Deng

    Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou, People’s Republic of China

    1 shared publication
  • Ying Zeng

    Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China

    1 shared publication

Latest Publications

  • Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors

    by Rui Zhang, Ying Zeng, Jun-Li Deng

    Long non-coding RNAs play important roles in cellular functions and disease development. H19, as a long non-coding RNA, is pervasively over-expressed in almost all kinds of human malignant tumors. Although many studies have reported that H19 is closely associated with tumor cell proliferation, apoptosis, invasion, metastasis, and chemoresistance, the role and mechanism of H19 in gene regulation and tumor development are largely unclear. In this review, we summarized the recent progress in the study of the major functions and mechanisms of H19 lncRNA in cancer development and progression. H19 possesses both oncogenic and tumor-suppressing activities, presumably through regulating target gene transcription, mRNA stability and splicing, and competitive inhibition of endogenous RNA degradation. Studies indicate that H19 may involve in cell proliferation and apoptosis, tumor initiation, migration, invasion, metastasis and chemoresistance and may serve as a potential biomarker for early diagnosis, prognosis, and novel molecular target for cancer therapy.